• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[放射性碘标记的间碘苄胍闪烁显像与CT在嗜铬细胞瘤定位中的比较]

[A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas].

作者信息

Rufini V, Troncone L, Valentini A L, Danza F M

机构信息

Istituti di Medicina Nucleare, Università Cattolica del Sacro Cuore, Roma.

出版信息

Radiol Med. 1988 Nov;76(5):466-70.

PMID:3205923
Abstract

In order to define the diagnostic roles of MIBG imaging and CT in the detection of pheochromocytomas (pheos), the results obtained in 45 patients suspected of bearing pheo and studied with both modalities were analyzed and compared. Scintigraphy was correctly negative in 22/23 cases, correctly positive in 11/12 adrenal and 5/5 extra-adrenal pheos, and in 4/5 malignant pheos (metastases present in 2 cases were also identified). CT was correctly negative in 20/23 cases (a mass other than a pheo was detected in 3 patients); correctly positive in 12/12 adrenal and 4/5 extra-adrenal pheos and in 5/5 malignant pheos. Sensitivity, specificity and accuracy of scintigraphy and CT were 91% and 95.4%, 95.6% and 87%, 93.3% and 91.1% respectively (differences were not statistically significant). The overall data emphasize the complementary role of 123/131I-MIBG imaging and CT in the location of pheochromocytomas. A flow-chart essentially grounded on the combined use of both these diagnostic modalities is proposed which includes 123/131I-MIBG scintigraphy as a first choice examination.

摘要

为了明确间碘苄胍(MIBG)显像和CT在嗜铬细胞瘤(pheo)检测中的诊断作用,对45例疑似患有嗜铬细胞瘤且接受了这两种检查的患者的结果进行了分析和比较。闪烁扫描在23例中的22例结果正确为阴性,在12例肾上腺嗜铬细胞瘤中的11例、5例肾上腺外嗜铬细胞瘤中的5例以及5例恶性嗜铬细胞瘤中的4例结果正确为阳性(还发现了2例存在转移的病例)。CT在23例中的20例结果正确为阴性(3例患者检测到非嗜铬细胞瘤的肿块);在12例肾上腺嗜铬细胞瘤中的12例、5例肾上腺外嗜铬细胞瘤中的4例以及5例恶性嗜铬细胞瘤中的5例结果正确为阳性。闪烁扫描和CT的敏感性、特异性和准确性分别为91%和95.4%、95.6%和87%、93.3%和91.1%(差异无统计学意义)。总体数据强调了123/131I-MIBG显像和CT在嗜铬细胞瘤定位中的互补作用。提出了一个主要基于这两种诊断方法联合使用的流程图,其中包括将123/131I-MIBG闪烁扫描作为首选检查。

相似文献

1
[A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas].[放射性碘标记的间碘苄胍闪烁显像与CT在嗜铬细胞瘤定位中的比较]
Radiol Med. 1988 Nov;76(5):466-70.
2
[131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].[疑似嗜铬细胞瘤患者的¹³¹I-间碘苄胍闪烁扫描。与CT及生物体液参数的比较]
Radiol Med. 1991 Dec;82(6):839-43.
3
Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.计算机断层扫描和¹³¹I-间碘苄胍闪烁显像在嗜铬细胞瘤诊断中的应用
Acta Radiol Diagn (Stockh). 1986 May-Jun;27(3):305-9. doi: 10.1177/028418518602700310.
4
[A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
Radiol Med. 1986 Jun;72(6):485-94.
5
Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.¹³¹I-间碘苄胍闪烁显像在定位嗜铬细胞瘤中的局限性。
Surgery. 1985 Jul;98(1):115-20.
6
Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation.嗜铬细胞瘤的定位:间碘苄胍(MIBG)[MIGB的校正]、CT及MRI相关性
J Nucl Med. 1989 Mar;30(3):328-36.
7
[Comparison of MIBG scintigraphy and computerized tomography in the localization of pheochromocytomas].[间碘苄胍闪烁扫描术与计算机断层扫描在嗜铬细胞瘤定位中的比较]
Arch Mal Coeur Vaiss. 1986 Jun;79(6):980-4.
8
Thallium-201 scintigraphy in the diagnosis of pheochromocytoma.铊-201闪烁扫描术在嗜铬细胞瘤诊断中的应用
Cardiology. 1985;72 Suppl 1:150-2. doi: 10.1159/000173963.
9
Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.嗜铬细胞瘤:使用碘131间碘苄胍闪烁显像法进行诊断。
South Med J. 1991 Oct;84(10):1221-30. doi: 10.1097/00007611-199110000-00015.
10
[Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].[¹³¹I-间碘苄胍闪烁扫描术诊断嗜铬细胞瘤]
Hinyokika Kiyo. 1990 Feb;36(2):105-8.

引用本文的文献

1
Diagnostic Performance of I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma.碘[131I]-间位碘苄胍 PET/CT 对嗜铬细胞瘤患者的诊断性能。
J Nucl Med. 2022 Jun;63(6):869-874. doi: 10.2967/jnumed.121.262797. Epub 2021 Sep 23.
2
Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.123I-间碘苄胍闪烁扫描术在评估已知或疑似原发性或转移性嗜铬细胞瘤或副神经节瘤患者中的应用价值:一项前瞻性多中心试验的结果
J Nucl Med. 2009 Sep;50(9):1448-54. doi: 10.2967/jnumed.108.058701. Epub 2009 Aug 18.
3
The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
放射性碘标记的间碘苄胍(MIBG)的诊断和治疗效用:5年经验
Eur J Nucl Med. 1990;16(4-6):325-35. doi: 10.1007/BF00842788.